TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival August 31, 2012